The Department of Health (DOH) and the Food and Drugs Administration (FDA) clarified claims on the approval of potential COVID-19 treatments and the call for the resignation of the Secretary of Health. ON THE INITIAL BANNING OF LIANHUA QINGWEN The DOH and the FDA would like to clarify that Lianhua Qingwen is a prescription medicine […]